Cargando…
Evaluation of dynamic recurrence risk for locally advanced gastric cancer in the clinical setting of adjuvant chemotherapy: a real-world study with IPTW-based conditional recurrence analysis
BACKGROUND: The long-term dynamic recurrence hazard of locally advanced gastric cancer (LAGC) in the clinical setting of adjuvant chemotherapy (ACT) remains unclear. PURPOSE: This study aimed to investigate the dynamic recurrence risk of LAGC in patients who received ACT or not. METHODS: The study a...
Autores principales: | Wu, Dong, Lu, Jun, Xue, Zhen, Zhong, Qing, Xu, Bin-bin, Zheng, Hua-Long, Lin, Guo-sheng, Shen, Li-li, Lin, Jia, Huang, Jiao-bao, Hakobyan, Davit, Li, Ping, Wang, Jia-Bin, Lin, Jian-Xian, Chen, Qi-Yue, Cao, Long-Long, Xie, Jian-Wei, Huang, Chang-Ming, Zheng, Chao-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568928/ https://www.ncbi.nlm.nih.gov/pubmed/37821825 http://dx.doi.org/10.1186/s12885-023-11143-3 |
Ejemplares similares
-
Is Adjuvant Chemotherapy Beneficial to All Patients With pT3N0M0 Stage Gastric Cancer?
por: Huang, Jiao-Bao, et al.
Publicado: (2021) -
An immune checkpoint score system for prognostic evaluation and adjuvant chemotherapy selection in gastric cancer
por: Wang, Jia-Bin, et al.
Publicado: (2020) -
Association of Adjuvant Chemotherapy With Overall Survival Among Patients With Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
por: Lin, Jian-Xian, et al.
Publicado: (2022) -
Clinical Impact of Delayed Initiation of Adjuvant Chemotherapy Among Patients With Stage II/III Gastric Cancer: Can We Do Better?
por: Chen, Qi-Yue, et al.
Publicado: (2020) -
TBX2 Expression predicts Tumor Recurrence and Adjuvant Chemotherapy Benefits in Gastric Cancer Patients following R0 Resection: a proposed approach for risk stratification
por: Lu, Jun, et al.
Publicado: (2020)